Dynamics and Half-Life of Cell-Free DNA After Exercise: Insights from a Fragment Size-Specific Measurement Approach

被引:2
作者
Yamamoto, Ryutaro [1 ]
Asano, Hiroshi [1 ]
Tamaki, Ryo [1 ]
Saito, Yoshihiro [1 ]
Hosokawa, Ami [1 ]
Watari, Hidemichi [1 ]
Umazume, Takeshi [1 ]
机构
[1] Hokkaido Univ Hosp, Dept Obstet, Sapporo 0608648, Japan
基金
日本科学技术振兴机构;
关键词
cell-free DNA; biomarker; circulating; half-life; clearance; fragment size; FREE PLASMA DNA; FETAL DNA; MATERNAL PLASMA; NUCLEIC-ACIDS; KINETICS; CLEARANCE; MARKER; TUBES;
D O I
10.3390/diagnostics15010109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cell-free DNA (cfDNA) is present in healthy individuals but is elevated in those undergoing physical exertion, trauma, sepsis, and certain cancers. Maintaining cfDNA concentrations is vital for immune homeostasis and preventing inflammatory responses. Understanding cfDNA release and clearance is essential for using cfDNA as a biomarker in clinical diagnostics. We focused on the fragment size of cfDNA and investigated cfDNA dynamics and half-life, particularly the 100-250 base pair fragments. Methods: Healthy, adult men (n = 5; age 40 +/- 4.1 years) were subjected to a 30 min treadmill exercise. Blood samples were collected at 0, 5, 10, 15, 30, and 60 min post-exercise using PAXgene (R) Blood ccfDNA tubes to stabilize and prevent nuclease-mediated cfDNA degradation and minimize genomic DNA contamination risk. The cfDNA concentration was measured using an electrophoresis-based technique (4150 TapeStation system) to quantify the concentration based on cfDNA fragment size. Results: The results showed a cfDNA half-life of 24.2 min, with a transient increase in 100-250 base pair cfDNA fragments post-exercise, likely due to nuclease activity. These levels rapidly reverted to the baseline within an hour. Conclusions: The rapid clearance of cfDNA underscores its potential as a biomarker for real-time disease monitoring and the evaluation of treatment efficacy. This study is expected to standardize cfDNA investigations, enhancing diagnosis and treatment monitoring across various disease conditions.
引用
收藏
页数:10
相关论文
共 35 条
[1]  
[Anonymous], 2003, AGILENT TECHNOLOGIES
[2]   Increased concentrations of cell-free plasma DNA after exhaustive exercise [J].
Atamaniuk, J ;
Vidotto, C ;
Tschan, H ;
Bachl, N ;
Stuhlmeier, KM ;
Müller, MM .
CLINICAL CHEMISTRY, 2004, 50 (09) :1668-1670
[3]   Cell-free plasma DNA and purine nucleotide degradation markers following weightlifting exercise [J].
Atamaniuk, Johanna ;
Vidotto, Claudia ;
Kinzlbauer, Markus ;
Bachl, Norbert ;
Tiran, Beate ;
Tschan, Harald .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2010, 110 (04) :695-701
[4]   Short-Term Treadmill Running as a Model for Studying Cell-Free DNA Kinetics In Vivo [J].
Beiter, Thomas ;
Fragasso, Annunziata ;
Hudemann, Jens ;
Niess, Andreas M. ;
Simon, Perikles .
CLINICAL CHEMISTRY, 2011, 57 (04) :633-636
[5]   Sequencing of Circulating Cell-free DNA during Pregnancy [J].
Bianchi, Diana W. ;
Chiu, Rossa W. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05) :464-473
[6]   Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise [J].
Breitbach, Sarah ;
Sterzing, Bjoern ;
Magallanes, Carlos ;
Tug, Suzan ;
Simon, Perikles .
JOURNAL OF APPLIED PHYSIOLOGY, 2014, 117 (02) :119-130
[7]   Circulating Cell-Free DNA An Up-Coming Molecular Marker in Exercise Physiology [J].
Breitbach, Sarah ;
Tug, Suzan ;
Simon, Perikles .
SPORTS MEDICINE, 2012, 42 (07) :565-586
[8]   Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases [J].
Celec, Peter ;
Vlkova, Barbora ;
Laukova, Lucia ;
Babickova, Janka ;
Boor, Peter .
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2018, 20
[9]   Circulating mutant DNA to assess tumor dynamics [J].
Diehl, Frank ;
Schmidt, Kerstin ;
Choti, Michael A. ;
Romans, Katharine ;
Goodman, Steven ;
Li, Meng ;
Thornton, Katherine ;
Agrawal, Nishant ;
Sokoll, Lori ;
Szabo, Steve A. ;
Kinzler, Kenneth W. ;
Vogelstein, Bert ;
Diaz, Luis A., Jr. .
NATURE MEDICINE, 2008, 14 (09) :985-990
[10]   A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage [J].
Fernando, M. R. ;
Chen, K. ;
Norton, S. ;
Krzyzanowski, G. ;
Bourne, D. ;
Hunsley, B. ;
Ryan, W. L. ;
Bassett, C. .
PRENATAL DIAGNOSIS, 2010, 30 (05) :418-424